ERS International Congress, Milan 2017

---

Migrants and screening

Thematic Poster
Chairs: D. Chesov (Chisinau, Republic of Moldova), S. Rosales-Klintz (Solna, Sweden), R. Ferreira Duarte Bessa Melo (Porto, Portugal)

Immigrants’ access to health care: problems identified in a high-risk tuberculosis population R. Linhas (Porto, Portugal)
Tuberculosis in Moldovan labour migrants L. Evelina (Chisinau, Republic of Moldova)
Active tuberculosis cases in migrants in Newham: should we extend screening criteria for latent tuberculosis infection G. Ransley (London, United Kingdom)
Impact of systematic screening on the burden of tuberculosis in Azerbaijan prisons E. Gurbanova (BAKU, Azerbaijan)
Treatment of DR-TB in penitential system of Georgia with new TB-medications. N. Kiria (Tbilisi, Georgia)
Incidence of latent tuberculosis infection(LTBI) among high risk healthcare workers at a tertiary referral hospital in South Korea. H. Kim (Seoul, Republic of Korea)
Opportunistic screening for Tuberculosis in homeless patients A. Banerjee (Eastleigh, United Kingdom)
Efficacy of isoniazid preventive therapy for latent tuberculosis infection in patients with immune-mediated inflammatory disorders-a retrospective cohort study in Taiwan W. Su (Taipei, Taiwan)
Tuberculosis in patients on TNFa inhibitor treatment in Latvia. A. Nodieva (Stopinu nov., Latvia)
Impact of enhanced case finding on case notification rate in pulmonary tuberculosis A. Prakash (GURGAON (HARYANA), India)
Contact tracing in pulmonary versus non-pulmonary tuberculosis- the impact of the 2016 NICE guidelines? C. Craig (Manchester, United Kingdom)
Review of Tuberculosis outbreak in a Boarding School in Bolton, United Kingdom R. Ahmed (Bolton, United Kingdom)
Are TB services in England adhering to new NICE guidelines on screening for latent TB? C. Craig (Manchester, United Kingdom)
Diaskintest at patients after successful treatment of lung tuberculosis G. Balasaniantc (Leningrad Oblast, Russian Federation)
Combinatorial ELISPOT and T-cell immunoprofiling with CD25+/CD134+ co-expression in latent TB infection P. Escalante (Rochester, United States of America)
Modulation of QuantiFERON-TB-Gold Plus response in patients with active tuberculosis and latent infection during treatment E. Petruccioli (Roma, Rm, Italy)